New Prognosis Model Predicts Risk of Respiratory Insufficiency or Death in ALS Patients, Study Says
Scientists created a new prognosis model to predict the risk of respiratory insufficiency or death within six months of…
Articles by Joana Carvalho, PhD
Enhanced Autophagy Can Alleviate Issues in ALS-linked Proteins, Study Says
Damaged activity of RNA-binding proteins (RBPs) associated with amyotrophic lateral sclerosis (ALS) can be alleviated by inducing autophagy, a process where…
Specific Molecular Patterns Could be a Strong Marker for ALS Progression and Prognosis, Study Contends
The patterns of methylation in arginine residues circulating in the cerebrospinal fluid — the liquid that circulates in the brain and…
Bacteria and Fungi Found in Central Nervous System of ALS Patients, Study Reports
Several species of bacteria and fungi were found living in the central nervous system (CNS) of patients with amyotrophic…
ALS MRI Marker May Facilitate Diagnosis and Monitoring, Study Finds
A magnetic resonance imaging (MRI) marker may facilitate amyotrophic lateral sclerosis (ALS) patients’ diagnosis and disease monitoring, a study finds.
Depression Before ALS Diagnosis Linked to Higher Risk of Cognitive Impairments
People affected by depression before being diagnosed with amyotrophic lateral sclerosis (ALS) have a higher risk of…
#AAN2019 – Pro Soccer Players More Likely to Develop ALS, Preliminary Study Says
Professional soccer players may be at higher risk of developing amyotrophic lateral sclerosis (ALS) compared to the general population.
Immune Response at the Root of Motor Neurons’ Death in ALS, Mouse Study Shows
An immune response triggered by T-cells contributed to the elimination of motor neurons in a mouse model of amyotrophic…
Swim Training Improves Muscle Function in Mouse Model of ALS, Study Shows
Swim training improves muscle strength and energy metabolism in a mouse model of amyotrophic lateral sclerosis (ALS). The study,…
CuATSM Therapy May Slow ALS Progression, Improving Cognition and Respiration in Patients, Phase 1 Trial Shows
CuATSM, one of the lead investigational therapies of Collaborative Medicinal Development (CMD), may slow disease progression and improve the…